Paper24809776
A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
Bendifallah S and 10 others. Br J Cancer, 2014. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. Papers, record 24809776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24809776
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endometrial Neoplasms | Major topic |
| Lymphatic Vessels | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Combined Modality Therapy | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Kaplan-Meier Estimate | |
| Lymphatic Metastasis | |
| Middle Aged | |
| Multivariate Analysis | |
| Neoplasm Invasiveness | |
| Neoplasm Staging | |
| Prognosis | |
| Prospective Studies | |
| Quality Improvement | |
| ROC Curve | |
| Risk | |
| Risk Assessment |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23770577 | Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. | Gynecol Oncol | 2013 | https://conductscience.org/library/papers/23770577 | PubMed |
| 2 | 7539772 | The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. | Gynecol Oncol | 1995 | https://conductscience.org/library/papers/7539772 | PubMed |
| 3 | 14984936 | A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. | Gynecol Oncol | 2004 | https://conductscience.org/library/papers/14984936 | PubMed |
| 4 | 19522800 | Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. | BJOG | 2009 | https://conductscience.org/library/papers/19522800 | PubMed |
| 5 | 23954391 | Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer. | Int J Gynaecol Obstet | 2013 | https://conductscience.org/library/papers/23954391 | PubMed |
| 6 | 1989916 | Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. | Gynecol Oncol | 1991 | https://conductscience.org/library/papers/1989916 | PubMed |
| 7 | 19033573 | Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. | J Natl Cancer Inst | 2008 | https://conductscience.org/library/papers/19033573 | PubMed |
| 8 | 21697683 | Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. | Int J Gynecol Cancer | 2011 | https://conductscience.org/library/papers/21697683 | PubMed |
| 9 | 19367689 | Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. | Int J Gynaecol Obstet | 2009 | https://conductscience.org/library/papers/19367689 | PubMed |
| 10 | 22155415 | Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? | Gynecol Oncol | 2012 | https://conductscience.org/library/papers/22155415 | PubMed |
| 11 | 17161155 | Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. | Int J Gynaecol Obstet | 2006 | https://conductscience.org/library/papers/17161155 | PubMed |
| 12 | 22576066 | Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22576066 | PubMed |
| 13 | 6822361 | Two pathogenetic types of endometrial carcinoma. | Gynecol Oncol | 1983 | https://conductscience.org/library/papers/6822361 | PubMed |
| 14 | 19070889 | Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. | Lancet | 2009 | https://conductscience.org/library/papers/19070889 | PubMed |
| 15 | 20206777 | Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. | Lancet | 2010 | https://conductscience.org/library/papers/20206777 | PubMed |
| 16 | 16330675 | Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/16330675 | PubMed |
| 17 | 3652025 | Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. | Cancer | 1987 | https://conductscience.org/library/papers/3652025 | PubMed |
| 18 | 23221731 | Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. | Int J Gynecol Cancer | 2013 | https://conductscience.org/library/papers/23221731 | PubMed |
| 19 | 24550988 | Endometrial cancer: molecular and cellular basis of tumor development, novel biomarkers and therapeutic agents, and innovative research approaches. | Obstet Gynecol Int | 2014 | https://conductscience.org/library/papers/24550988 | PubMed |
| 20 | 12468325 | Surgical stage I endometrial cancer: predictors of distant failure and death. | Gynecol Oncol | 2002 | https://conductscience.org/library/papers/12468325 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42973791 | A nomogram integrating YTHDC2 expression and clinicopathological parameters for predicting endometrial cancer recurrence: a multicenter retrospective study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42973791 | PubMed |
| 42482756 | A novel nomogram incorporating preoperative systemic inflammatory response index and clinicopathological parameters for predicting lymph node metastasis in endometrial cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42482756 | PubMed |
| 40973043 | Bridging adjuvant treatment gaps: low and intermediate risk endometrial carcinoma patients care in Salah Azaiez Institute in Tunisia. | Oncologist | 2025 | https://conductscience.org/library/papers/40973043 | PubMed |
| 40304351 | Analysis of the Correlation between MRI Imaging Signs and Lymphovascular Space Invasion in Endometrial Cancer | Curr Med Imaging | 2025 | https://conductscience.org/library/papers/40304351 | PubMed |
| 39610926 | Guiding adjuvant radiotherapy in stage III endometrial cancer: a prognostic model based on SEER. | Front Oncol | 2024 | https://conductscience.org/library/papers/39610926 | PubMed |
| 38916618 | Both intra- and peri-tumoral radiomics signatures can be used to predict lymphatic vascular space invasion and lymphatic metastasis positive status from endometrial cancer MR imaging. | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/38916618 | PubMed |
| 38775501 | Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer. | Rev Assoc Med Bras (1992) | 2024 | https://conductscience.org/library/papers/38775501 | PubMed |
| 37963944 | Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma. | Sci Rep | 2023 | https://conductscience.org/library/papers/37963944 | PubMed |
| 37153054 | Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37153054 | PubMed |
| 36915143 | The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer. | Eur J Med Res | 2023 | https://conductscience.org/library/papers/36915143 | PubMed |
| 36662766 | Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis. | PLoS One | 2023 | https://conductscience.org/library/papers/36662766 | PubMed |
| 36523313 | The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis. | Transl Cancer Res | 2022 | https://conductscience.org/library/papers/36523313 | PubMed |
| 35453837 | Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35453837 | PubMed |
| 35225474 | Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/35225474 | PubMed |
| 35114747 | The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results. | Mol Imaging Radionucl Ther | 2022 | https://conductscience.org/library/papers/35114747 | PubMed |
| 34553020 | Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/34553020 | PubMed |
| 34485158 | A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34485158 | PubMed |
| 34220310 | Prediction of lymphovascular space invasion in patients with endometrial cancer. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/34220310 | PubMed |
| 34137929 | Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma. | Eur Radiol | 2022 | https://conductscience.org/library/papers/34137929 | PubMed |
| 33856667 | The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy? | Reprod Sci | 2022 | https://conductscience.org/library/papers/33856667 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24809776
GET https://conductscience.org/api/papers/v1/24809776/references?page=2